Materials And Products Tenders

Medicines with the Active Ingredient Fentanyl (Atc: N02ab03 - Except Matrix Patches and Tablets)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Budesonide, Atc A07ea06 for the Period March 1St, 2024 - February 28Th, 202...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Metronidazole, Atc D06bx01 for the Period March 1St, 2024 - February 28Th,...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Isosorbide Mononitrate, Atc C01da14 for the Period March 1St, 2024 - Februa...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Benazepril Hydrochlorothiazide, Atc C09ba27 for the Period March 1St, 2024...

Medicines with the Active Ingredient Lacosamide (Atc: N03ax18 - Except Film-Coated Tablets)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Dexketoprofen, Atc M01ae17 for the Period March 1St, 2024 - February 28Th,...

Medicines with the Active Ingredient Edoxaban (Atc: B01af03)

Medicines with the Active Ingredient Dronedarone (Atc: C01bd07)

Medicines with the Active Ingredient Apixaban (Atc: B01af02)